{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2011-N-0103\" sorted by posted_date descending", "rows": [["FDA-2011-N-0103-0025", "FDA", "FDA-2011-N-0103", "Reference 6 Specific Identification of Bacillus anthracis", "Supporting & Related Material", "Background Material", "2019-04-01T04:00:00Z", 2019, 4, null, null, "2019-04-01T16:17:03Z", null, 0, 0, "0900006483b53a23"], ["FDA-2011-N-0103-0023", "FDA", "FDA-2011-N-0103", "Reference 8 Phage Isolated from Lysogenic Bacillus anthracis", "Supporting & Related Material", "Background Material", "2019-04-01T04:00:00Z", 2019, 4, null, null, "2019-04-01T16:17:01Z", null, 0, 0, "0900006483b53a25"], ["FDA-2011-N-0103-0028", "FDA", "FDA-2011-N-0103", "Reference 3 Regulatory Flexibility Analysis", "Supporting & Related Material", "Background Material", "2019-04-01T04:00:00Z", 2019, 4, null, null, "2019-04-01T16:17:05Z", null, 0, 0, "0900006483b53976"], ["FDA-2011-N-0103-0026", "FDA", "FDA-2011-N-0103", "Reference 5 Production and Validation of the Use of Gamma Phage", "Supporting & Related Material", "Background Material", "2019-04-01T04:00:00Z", 2019, 4, null, null, "2019-04-01T16:17:04Z", null, 0, 0, "0900006483b53978"], ["FDA-2011-N-0103-0027", "FDA", "FDA-2011-N-0103", "Reference 4 Abshire T.G. et at Validation ofthe use of gamma phage for identifying Bacillus anthracis", "Supporting & Related Material", "Background Material", "2019-04-01T04:00:00Z", 2019, 4, null, null, "2019-04-01T16:17:04Z", null, 0, 0, "0900006483b53977"], ["FDA-2011-N-0103-0024", "FDA", "FDA-2011-N-0103", "Reference 7 Differential Diagnosis of Bacillus cereus", "Supporting & Related Material", "Background Material", "2019-04-01T04:00:00Z", 2019, 4, null, null, "2019-04-01T16:17:02Z", null, 0, 0, "0900006483b53a24"], ["FDA-2011-N-0103-0030", "FDA", "FDA-2011-N-0103", "Reference 1 Class II Special Controls Guideline", "Supporting & Related Material", "Background Material", "2019-04-01T04:00:00Z", 2019, 4, null, null, "2019-04-01T16:17:06Z", null, 0, 0, "0900006483b53974"], ["FDA-2011-N-0103-0031", "FDA", "FDA-2011-N-0103", "Index to References FR", "Supporting & Related Material", "Background Material", "2019-04-01T04:00:00Z", 2019, 4, null, null, "2019-04-01T16:17:07Z", null, 0, 0, "0900006483b53d58"], ["FDA-2011-N-0103-0029", "FDA", "FDA-2011-N-0103", "Reference 2 Transcript of the FDA Microbiology Devices Panel Meeting March 7 2002", "Supporting & Related Material", "Background Material", "2019-04-01T04:00:00Z", 2019, 4, null, null, "2019-04-01T16:17:06Z", null, 0, 0, "0900006483b53975"], ["FDA-2011-N-0103-0021", "FDA", "FDA-2011-N-0103", "Microbiology Devices; Classification of In Vitro Diagnostic Devices for Bacillus Species Detection", "Rule", "Final Rule", "2019-04-01T04:00:00Z", 2019, 4, "2019-04-01T04:00:00Z", null, "2019-04-01T15:56:15Z", "2019-06026", 0, 0, "0900006483b512a0"], ["FDA-2011-N-0103-0022", "FDA", "FDA-2011-N-0103", "Reference 9 A colour Atlas of Bacillus Species", "Supporting & Related Material", "Background Material", "2019-04-01T04:00:00Z", 2019, 4, null, null, "2019-04-01T16:17:00Z", null, 0, 0, "0900006483b53a26"], ["FDA-2011-N-0103-0016", "FDA", "FDA-2011-N-0103", "Reference 6 - Phage Isolated From Lysogenic Bacillus Anthracis", "Supporting & Related Material", "Background Material", "2016-01-12T05:00:00Z", 2016, 1, null, null, "2016-01-12T18:39:37Z", null, 0, 0, "0900006481e03459"], ["FDA-2011-N-0103-0017", "FDA", "FDA-2011-N-0103", "Reference 7 - A Colour Atlas of Bacillus Species", "Supporting & Related Material", "Background Material", "2016-01-12T05:00:00Z", 2016, 1, null, null, "2016-01-12T18:39:45Z", null, 0, 0, "0900006481e0345a"], ["FDA-2011-N-0103-0018", "FDA", "FDA-2011-N-0103", "Reference 8 - Draft Guideline for Industry and FDA Staff Class II Special Controls Guidline: In Vitro Diagnostic Devices for Bacillus spp. Detection", "Supporting & Related Material", "Background Material", "2016-01-12T05:00:00Z", 2016, 1, null, null, "2016-01-12T18:39:51Z", null, 0, 0, "0900006481e0345e"], ["FDA-2011-N-0103-0015", "FDA", "FDA-2011-N-0103", "Reference 5 - Differential Diagnosis of Bacillus Cereus Bacillus Anthracis and Bacillus Cereus Var. Mycoides", "Supporting & Related Material", "Background Material", "2016-01-12T05:00:00Z", 2016, 1, null, null, "2016-01-12T18:39:33Z", null, 0, 0, "0900006481e032e5"], ["FDA-2011-N-0103-0012", "FDA", "FDA-2011-N-0103", "Reference 2 - Validation of the use of Gamma Phage for Identifying Bacillus Anthracis", "Supporting & Related Material", "Background Material", "2016-01-12T05:00:00Z", 2016, 1, null, null, "2016-01-12T18:39:19Z", null, 0, 0, "0900006481e032b1"], ["FDA-2011-N-0103-0014", "FDA", "FDA-2011-N-0103", "Reference 4 - Specific Identification of Bacillus Anthracis by Means of a Variant Bacteriophage", "Supporting & Related Material", "Background Material", "2016-01-12T05:00:00Z", 2016, 1, null, null, "2016-01-12T18:39:29Z", null, 0, 0, "0900006481e032e4"], ["FDA-2011-N-0103-0011", "FDA", "FDA-2011-N-0103", "Reference 1 -  Transcript of Microbiology Devices Panel meeting March 7 2002", "Supporting & Related Material", "Background Material", "2016-01-12T05:00:00Z", 2016, 1, null, null, "2016-01-12T18:39:15Z", null, 0, 0, "0900006481e02ead"], ["FDA-2011-N-0103-0010", "FDA", "FDA-2011-N-0103", "List of References", "Supporting & Related Material", "List", "2016-01-12T05:00:00Z", 2016, 1, null, null, "2016-01-12T18:39:10Z", null, 0, 0, "0900006481e031a7"], ["FDA-2011-N-0103-0013", "FDA", "FDA-2011-N-0103", "Reference 3 - Production and Validation of the Use of Gamma Phage for the Identification of Bacillus Anthracis", "Supporting & Related Material", "Background Material", "2016-01-12T05:00:00Z", 2016, 1, null, null, "2016-01-12T18:39:25Z", null, 0, 0, "0900006481e032b2"], ["FDA-2011-N-0103-0019", "FDA", "FDA-2011-N-0103", "Reference 9 - Microbiology Devices; Classification of In Vitro Diagnostic Device for Bacillus Species Detection - Preliminary Regulatory Impact Analysis, Initial Regulatory Flexibility Analysis, and Unfunded Mandates Reform Act Analysis", "Supporting & Related Material", "Background Material", "2016-01-12T05:00:00Z", 2016, 1, null, null, "2016-01-12T18:39:55Z", null, 0, 0, "0900006481e0345f"], ["FDA-2011-N-0103-0020", "FDA", "FDA-2011-N-0103", "Reference 10 - Laboratory Response Network LRN Level A laboratory procedures for identification of Bacillus Anthracis", "Supporting & Related Material", "Background Material", "2016-01-12T05:00:00Z", 2016, 1, null, null, "2016-01-12T18:40:02Z", null, 0, 0, "0900006481e034a8"], ["FDA-2011-N-0103-0008", "FDA", "FDA-2011-N-0103", "Microbiology Devices; Classification of In Vitro Diagnostic Devices for Bacillus Species Detection", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2015-11-17T05:00:00Z", 2015, 11, "2015-11-17T05:00:00Z", "2016-02-17T04:59:59Z", "2015-12-10T22:00:47Z", "2015-29275", 0, 0, "0900006481d4d5ce"], ["FDA-2011-N-0103-0004", "FDA", "FDA-2011-N-0103", "Reference 2 - Abshire, T.G. et at, \"Validation ofthe use of gamma phage for identifying Bacillus anthracis,It 102nd American Society for Microbiology Annual Meeting poster #C 122, 2001 [5/18/2011 Notice of Proposed Rule]", "Supporting & Related Material", "BKG-Background Material", "2011-05-18T04:00:00Z", 2011, 5, null, null, "2011-05-18T16:06:05Z", null, 0, 0, "0900006480d4366e"], ["FDA-2011-N-0103-0002", "FDA", "FDA-2011-N-0103", "List of References", "Supporting & Related Material", "BKG-Background Material", "2011-05-18T04:00:00Z", 2011, 5, null, null, "2016-01-12T16:29:28Z", null, 0, 0, "0900006480d43669"], ["FDA-2011-N-0103-0005", "FDA", "FDA-2011-N-0103", "Reference 3 - Brown, Eric R. and William B. Cherry, \"Specific identification ofBacillus anthracis by means of a variant bacteriophage,\" vol. 96, Journal of Infectious Disease, p. 34, 2001 [5/18/2011 Notice of Proposed Rule]", "Supporting & Related Material", "BKG-Background Material", "2011-05-18T04:00:00Z", 2011, 5, null, null, "2011-05-18T16:06:07Z", null, 0, 0, "0900006480d4366f"], ["FDA-2011-N-0103-0006", "FDA", "FDA-2011-N-0103", "Reference 4 - Brown, Eric R. et aI., \"Differential diagnosis of Bacillus cereus, Bacillus anthracis and Bacillus cereus var. ,nycoides,\" vol. 75, Journal of Bacteriology, p. 499, 1957 [5/18/2011 Notice of Proposed Rule]", "Supporting & Related Material", "BKG-Background Material", "2011-05-18T04:00:00Z", 2011, 5, null, null, "2011-05-18T16:06:09Z", null, 0, 0, "0900006480d43a26"], ["FDA-2011-N-0103-0001", "FDA", "FDA-2011-N-0103", "Microbiology Devices: Classification of In Vitro Diagnostic Device for Bacillus Species Detection", "Proposed Rule", "NPR-Notice of Proposed Rule-Making", "2011-05-18T04:00:00Z", 2011, 5, "2011-05-18T04:00:00Z", "2011-08-17T03:59:59Z", "2011-05-18T13:52:27Z", "2011-12088", 0, 0, "0900006480d4154e"], ["FDA-2011-N-0103-0003", "FDA", "FDA-2011-N-0103", "Reference 1 -Transcript of the FDA Microbiology Devices Panel meeting, March 7. 2002, at: http://www.accessdata.fda.gov/scripts/cdrhlcfdocs/cfAdvisory/details.cfm?mtg=348 [5/18/2011 Notice of Proposed Rule]", "Supporting & Related Material", "BKG-Background Material", "2011-05-18T04:00:00Z", 2011, 5, null, null, "2011-05-18T16:06:03Z", null, 0, 0, "0900006480d4366b"]], "truncated": false, "filtered_table_rows_count": 29, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2011-N-0103"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103", "results": [{"value": "FDA", "label": "FDA", "count": 29, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2011-N-0103", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 26, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&document_type=Proposed+Rule", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103", "results": [{"value": 2016, "label": 2016, "count": 11, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&posted_year=2016", "selected": false}, {"value": 2019, "label": 2019, "count": 11, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&posted_year=2019", "selected": false}, {"value": 2011, "label": 2011, "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&posted_year=2011", "selected": false}, {"value": 2015, "label": 2015, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&posted_year=2015", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "title", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&_facet=title"}, {"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&_facet=posted_month"}, {"name": "last_modified", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&_facet=last_modified"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0103&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 44.18998898472637, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}